ACL-514

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameACL-514
Drug Alias NameCKD-514CKD514ACL-514
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical CorpArchela Inc
China Registration ClassN/A

Develop Information

Active CompaniesArchela IncChong Kun Dang Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A